The Biotech Job Board
Built by Scientists
for Scientists

Where Science Careers Launch
Qu Biologics
Qu Biologics

Qu Biologics is a Vancouver-based, private, clinical stage biotechnology company developing Site Specific Immunomodulators (SSI), a novel proprietary immunotherapy platform. SSIs are designed to stimulate an innate immune response in targeted organs or tissues to reverse the chronic inflammation underlying many diseases including cancer and inflammatory bowel disease (Crohn's disease, ulcerative colitis). SSIs aim to restore immune function and have potential broad applicability across a wide variety chronic diseases. The company has initiated three clinical trials in Crohn's disease, ulcerative colitis and lung cancer.
Burnaby, BC, Canada
Inaccurate data? Flag it here.
Open jobs at Qu Biologics